ELEVATE, a Registry of Patients With Acute Hepatic Porphyria (AHP)
NCT04883905 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 150
Last updated 2026-04-27
Summary
This global patient registry is being conducted to characterize the natural history and real-world clinical management of patients with AHP, and to further characterize the real-world safety and effectiveness of givosiran and other approved AHP therapies.
Conditions
- Acute Hepatic Porphyria
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Alnylam Pharmaceuticals
Eligibility
- Min Age
- 12 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-04-26
- Primary Completion
- 2027-04-01
- Completion
- 2027-04-01
Countries
- United States
- Belgium
- France
- Germany
- Italy
- Spain
- Sweden
- Switzerland
- Taiwan
- United Kingdom
Study Locations
More Related Trials
-
Phase 2 Evaluation of the ELAD System in the Management of Acute Liver Failure
NCT00030225 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Test Whether Avenciguat Helps People With Liver Cirrhosis and High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver) Who Had Bleeding in the Esophagus or Fluid Accumulation in the Belly
NCT06082843 ·Status: TERMINATED ·Phase: PHASE2
-
Hematological Disorders in EHPVO Patients
NCT07108023 ·Status: NOT_YET_RECRUITING
-
Non-invasive Evaluation Program for TIPS and Follow Up Network
NCT03628807 ·Status: COMPLETED
-
Characterization of Metabolomic Fingerprints in Patients With Acute Liver Failure and Acute-on-chronic Liver Failure With Hepatic Encephalopathy
NCT05772585 ·Status: WITHDRAWN
-
A Study to Test Whether BI 685509 Alone or in Combination With Empagliflozin Helps People With Liver Cirrhosis Caused by Viral Hepatitis or Non-alcoholic Steatohepatitis (NASH) Who Have High Blood Pressure in the Portal Vein (Main Vessel Going to the Liver)
NCT05282121 ·Status: TERMINATED ·Phase: PHASE2
-
A Study of the Effect of Plasmaexchange in Patients With Acute Liver Failure
NCT00950508 ·Status: COMPLETED ·Phase: NA
-
Efficacy and Safety of AXA1665 in Cirrhotic Subjects With Prior Overt Hepatic Encephalopathy
NCT04816916 ·Status: TERMINATED ·Phase: PHASE2
-
HepHospital: A Pilot Trial of a Hepatology Home Hospital Intervention for Patients With Advanced Liver Disease
NCT05205954 ·Status: RECRUITING ·Phase: NA
-
A Multi-Center Trial to Study Acute Liver Failure in Adults
NCT00518440 ·Status: COMPLETED
-
Liver Disease in Pregnancy
NCT03834285 ·Status: UNKNOWN
-
Early TIPS for Ascites Study
NCT01236339 ·Status: TERMINATED ·Phase: NA
-
Pentoxifylline for Acute Alcoholic Hepatitis (AAH)
NCT00205049 ·Status: TERMINATED ·Phase: PHASE1
-
Effects of Long-Term Administration of Human Albumin in Participants With Decompensated Cirrhosis and Ascites
NCT03451292 ·Status: COMPLETED ·Phase: PHASE3
-
ALTA TIPS: A 5-year Longitudinal Observational Study of Patients Undergoing TIPS Placement
NCT03973372 ·Status: ACTIVE_NOT_RECRUITING
-
Study of Aldafermin (NGM282) in Subjects With Compensated Cirrhosis (ALPINE 4)
NCT04210245 ·Status: COMPLETED ·Phase: PHASE2
-
Apixaban Prevents Portal Vein Thrombosis After Laparoscopic Splenectomy and Azygoportal Disconnection
NCT05304455 ·Status: COMPLETED ·Phase: NA
-
A Multi-Center Group to Study Acute Liver Failure in Children
NCT00986648 ·Status: COMPLETED
-
Assessing Outcome After H-graft Shunt Placement
NCT00519610 ·Status: COMPLETED
-
Efficacy & Safety of Anticoagulants in Cirrhosis ± HCC
NCT07132515 ·Status: RECRUITING ·Phase: PHASE4
-
Integrative Epidemiology of Prognosis in Patients With Acute Alcoholic Hepatitis at AP-HP
NCT07262515 ·Status: RECRUITING
-
Predicting Acute-on-Chronic Liver Failure in Cirrhosis (PREDICT) Study
NCT03056612 ·Status: COMPLETED
-
Correlation Between Serum Albumin Level and Severity of Hepatic Encephalopathy in Patients With Chronic Liver Disease in Sohag University Hospital
NCT06953921 ·Status: RECRUITING
-
TIPS in Patients With Decompensated Liver Cirrhosis
NCT04801290 ·Status: RECRUITING
-
Effect of Long-term Carvedilol to Prevent Decompensation or Death in Patients With Asymptomatic Child-Pugh A5 to B8 Cirrhosis and Clinically Significant Portal Hypertension: a Multicenter Double-blind Randomized Control Trial
NCT06263816 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3